Andere Sprachen enGene Holdings Inc.

Aktien

ENGN

CA29286M1059

ENGN

Schlusskurs Nasdaq Andere Börsenplätze 00:00:00 15.05.2024			% 5 Tage	% 1. Jan.
13,62 ^USD	-4,35 %		-4,29 %	+47,56 %

15.05.	EnGene Holdings Inc. genehmigt Vorstandsernennungen	CI
23.04.	ENGENE HOLDINGS INC. : Wells Fargo Securities bleibt bei seiner Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

EnGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors	15.05.
EnGene Holdings Inc. Approves Board Appointments	15.05.
EnGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting	02.05.
EnGene Announces Hiring of Dr. Raj Pruthi as Senior Vice President, Urologic Oncology and Clinical Development	10.04.
/C O R R E C T I O N -- enGene Inc./	09.04.
EnGene Holdings Inc. Appoints Raj Pruthi as SVP, Urologic Oncology and Clinical Development	09.04.
EnGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress	11.03.
EnGene Holdings Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	11.03.
EnGene : Reports First Quarter 2024 Financial Results and Recent Corporate Progress - Form 8-K	11.03.
EnGene To Present at the Leerink Partners Global Biopharma Conference	05.03.
EnGene Holdings Inc. announced that it has received CAD 200 million in funding from a group of investors	20.02.
Top Midday Gainers	14.02.
EnGene Announces Oversubscribed $200 Million Private Placement Financing	14.02.
EnGene Announces Leadership Succession Plan	14.02.
EnGene Holdings Inc. Announces Resignation of Jason Hanson as Member of the Board of Directors	14.02.
EnGene Holdings Inc. Announces Resignation of Jason Hanson as Chief Executive Officer	14.02.
EnGene Holdings Inc. announced that it expects to receive CAD 200 million in funding from a group of investors	14.02.
EnGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary	30.01.
EnGene Holdings Inc. Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary	30.01.
EnGene Reports Full Year 2023 Financial Results and Recent Operational Progress	29.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen enGene Holdings Inc.

Aktien

ENGN

CA29286M1059

ENGN

Andere Sprachen

Filter